Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;9(5):3659-3660.
doi: 10.1002/ehf2.14047. Epub 2022 Jun 21.

So-far overlooked HFpEF patients with normal natriuretic peptide level need more evidence

Atsushi Tanaka  1 , Koichi Node  1
Affiliations
Comment

So-far overlooked HFpEF patients with normal natriuretic peptide level need more evidence

Atsushi Tanaka et al. ESC Heart Fail. 2022 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, et al. N‐terminal pro‐brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study. Arterioscler Thromb Vasc Biol. 2011; 31: 2997–3003. - PubMed
    1. Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, et al. The prognostic value of the plasma N‐terminal pro‐brain natriuretic peptide level on all‐cause death and major cardiovascular events in a community‐based population. Clin Interv Aging. 2016; 11: 245–253. - PMC - PubMed
    1. Verbrugge FH, Omote K, Reddy YNV, Sorimachi H, Obokata M, Borlaug BA. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J. 2022; 43: 1941–1951. - PMC - PubMed
    1. Packer M, Zannad F, Anker SD. Heart failure and a preserved ejection fraction: a side‐by‐side examination of the PARAGON‐HF and EMPEROR‐Preserved trials. Circulation. 2021; 144: 1193–1195. - PubMed
    1. Ibrahim NE, Burnett JC Jr, Butler J, Camacho A, Felker GM, Fiuzat M, et al. Natriuretic peptides as inclusion criteria in clinical trials: a JACC: heart failure position paper. JACC Heart Fail. 2020; 8: 347–358. - PubMed